To include your compound in the COVID-19 Resource Center, submit it here.

Roche's product deal flow

Roche's product deal flow

Date Partner Disease area Status at time of deal Deal
4/9/02 Isotechnika (TSE:ISA) Autoimmune/Inflammation, Transplant Ph II Will co-develop ISA's ISA247, a calcineurin inhibitor immunosuppressant in Phase

Read the full 314 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE